Literature DB >> 27053151

Integrated analysis of proteome and transcriptome changes in the mucopolysaccharidosis type VII mouse hippocampus.

Michael K Parente1, Ramona Rozen1, Steven H Seeholzer1, John H Wolfe2.   

Abstract

Mucopolysaccharidosis type VII (MPS VII) is a lysosomal storage disease caused by the deficiency of β-glucuronidase. In this study, we compared the changes relative to normal littermates in the proteome and transcriptome of the hippocampus in the C57Bl/6 mouse model of MPS VII, which has well-documented histopathological and neurodegenerative changes. A completely different set of significant changes between normal and MPS VII littermates were found in each assay. Nevertheless, the functional annotation terms generated by the two methods showed agreement in many of the processes, which also corresponded to known pathology associated with the disease. Additionally, assay-specific changes were found, which in the proteomic analysis included mitochondria, energy generation, and cytoskeletal differences in the mutant, while the transcriptome differences included immune, vesicular, and extracellular matrix changes. In addition, the transcriptomic changes in the mutant hippocampus were concordant with those in a MPS VII mouse caused by the same mutation but on a different background inbred strain.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GUSB; Hippocampus; Lysosomal storage disease; MPS VII; Mitochondria; Mucopolysaccharidosis type VII; Neurodegeneration; Proteomic analysis; Transcriptome; β-Glucuronidase

Mesh:

Year:  2016        PMID: 27053151      PMCID: PMC4832927          DOI: 10.1016/j.ymgme.2016.03.003

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  46 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

2.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

Review 3.  The complement system: an unexpected role in synaptic pruning during development and disease.

Authors:  Alexander H Stephan; Ben A Barres; Beth Stevens
Journal:  Annu Rev Neurosci       Date:  2012       Impact factor: 12.449

Review 4.  Data merging for integrated microarray and proteomic analysis.

Authors:  Katrina M Waters; Joel G Pounds; Brian D Thrall
Journal:  Brief Funct Genomic Proteomic       Date:  2006-05-10

Review 5.  Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress.

Authors:  Laszlo Tretter; Vera Adam-Vizi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

Review 6.  A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation?

Authors:  Haitao Wen; Jenny P-Y Ting; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2012-03-19       Impact factor: 25.606

Review 7.  OXPHOS mutations and neurodegeneration.

Authors:  Werner J H Koopman; Felix Distelmaier; Jan A M Smeitink; Peter H G M Willems
Journal:  EMBO J       Date:  2012-11-13       Impact factor: 11.598

8.  Lysosomal dysfunction results in altered energy balance.

Authors:  Josh C Woloszynek; Trey Coleman; Clay F Semenkovich; Mark S Sands
Journal:  J Biol Chem       Date:  2007-10-02       Impact factor: 5.157

9.  Ex vivo gene therapy using patient iPSC-derived NSCs reverses pathology in the brain of a homologous mouse model.

Authors:  Tagan A Griffin; Hayley C Anderson; John H Wolfe
Journal:  Stem Cell Reports       Date:  2015-04-09       Impact factor: 7.765

10.  Integrated analysis of transcriptomic and proteomic data.

Authors:  Saad Haider; Ranadip Pal
Journal:  Curr Genomics       Date:  2013-04       Impact factor: 2.236

View more
  11 in total

1.  Metabolomics profiling reveals profound metabolic impairments in mice and patients with Sandhoff disease.

Authors:  Li Ou; Michael J Przybilla; Chester B Whitley
Journal:  Mol Genet Metab       Date:  2018-09-14       Impact factor: 4.797

Review 2.  The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy.

Authors:  Anna-Maria Wiesinger; Brian Bigger; Roberto Giugliani; Maurizio Scarpa; Tobias Moser; Christina Lampe; Christoph Kampmann; Florian B Lagler
Journal:  Front Pharmacol       Date:  2022-05-13       Impact factor: 5.988

Review 3.  Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders.

Authors:  Wenping Li; Stephanie M Cologna
Journal:  Mol Omics       Date:  2022-05-11

4.  Transcriptomic Changes Related to Cellular Processes with Particular Emphasis on Cell Activation in Lysosomal Storage Diseases from the Group of Mucopolysaccharidoses.

Authors:  Estera Rintz; Lidia Gaffke; Magdalena Podlacha; Joanna Brokowska; Zuzanna Cyske; Grzegorz Węgrzyn; Karolina Pierzynowska
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 5.923

5.  Lysosomal and network alterations in human mucopolysaccharidosis type VII iPSC-derived neurons.

Authors:  Neus Bayó-Puxan; Ana Paula Terrasso; Sophie Creyssels; Daniel Simão; Christina Begon-Pescia; Marina Lavigne; Sara Salinas; Florence Bernex; Assumpció Bosch; Vasiliki Kalatzis; Thierry Levade; Ana Maria Cuervo; Philippe Lory; Antonella Consiglio; Catarina Brito; Eric J Kremer
Journal:  Sci Rep       Date:  2018-11-09       Impact factor: 4.379

6.  Identification of the iduronate-2-sulfatase proteome in wild-type mouse brain.

Authors:  Carolina Cardona; Eliana Benincore; Natalia Pimentel; Luis H Reyes; Camilo Patarroyo; Alexander Rodríguez-López; M Martin-Rufian; Luis Alejandro Barrera; Carlos J Alméciga-Díaz
Journal:  Heliyon       Date:  2019-05-10

Review 7.  Cathepsins in the Pathophysiology of Mucopolysaccharidoses: New Perspectives for Therapy.

Authors:  Valeria De Pasquale; Anna Moles; Luigi Michele Pavone
Journal:  Cells       Date:  2020-04-15       Impact factor: 6.600

8.  Genetic Base of Behavioral Disorders in Mucopolysaccharidoses: Transcriptomic Studies.

Authors:  Karolina Pierzynowska; Lidia Gaffke; Magdalena Podlacha; Grzegorz Węgrzyn
Journal:  Int J Mol Sci       Date:  2020-02-10       Impact factor: 5.923

9.  THAP1 modulates oligodendrocyte maturation by regulating ECM degradation in lysosomes.

Authors:  Dhananjay Yellajoshyula; Samuel S Pappas; Abigail E Rogers; Biswa Choudhury; Xylena Reed; Jinhui Ding; Mark R Cookson; Vikram G Shakkottai; Roman J Giger; William T Dauer
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-03       Impact factor: 11.205

10.  Brain RNA-Seq Profiling of the Mucopolysaccharidosis Type II Mouse Model.

Authors:  Marika Salvalaio; Francesca D'Avanzo; Laura Rigon; Alessandra Zanetti; Michela D'Angelo; Giorgio Valle; Maurizio Scarpa; Rosella Tomanin
Journal:  Int J Mol Sci       Date:  2017-05-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.